ImmunityBio, Inc.
IBRX
$2.84
$0.176.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -119.14% | 30.99% | 36.29% | -0.34% | 42.54% |
| Total Depreciation and Amortization | -7.47% | -7.12% | 1.11% | -3.27% | -0.20% |
| Total Amortization of Deferred Charges | -- | -19.23% | 6.29% | 5.10% | -22.04% |
| Total Other Non-Cash Items | 355.08% | -78.07% | -173.26% | -11.00% | -84.18% |
| Change in Net Operating Assets | -103.24% | -7.88% | -287.40% | 237.76% | 84.88% |
| Cash from Operations | -0.89% | 13.79% | 1.58% | 6.20% | 7.19% |
| Capital Expenditure | 46.90% | 24.39% | -285.64% | 42.59% | 84.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.05% | -82.39% | 233.60% | -47.74% | -436.74% |
| Cash from Investing | -58.01% | -84.88% | 226.30% | -44.55% | -1,683.90% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -4.76% | 0.00% | -5.00% |
| Issuance of Common Stock | -99.80% | 577.43% | -69.68% | 271.58% | 50.86% |
| Repurchase of Common Stock | -49.69% | -168.56% | 39.72% | 87.17% | -147.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -200.00% | 3,232,066.67% | -- |
| Cash from Financing | -100.92% | 586.23% | -89.53% | 1,356.18% | -94.90% |
| Foreign Exchange rate Adjustments | -42.86% | -163.64% | -8.33% | 130.77% | -44.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -361.82% | 274.29% | -518.83% | 97.79% | -251.35% |